Welcome to the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)

The FMP conducts basic research in Molecular Pharmacology with the aim to identify novel bioactive molecules and to characterize their interactions with their biological targets in cells or organisms. These compounds are useful tools in basic biomedical research and may be further developed for the treatment, prevention, or diagnosis of disease.
To this aim FMP researchers study key biological processes and corresponding diseases, such as cancer, aging including osteoporosis, or neurodegeneration. They also develop and apply advanced technologies ranging from screening technologies over NMR based methods to proteomics and in vivo models.

Highlight 2017

Symposium Perspectives in Molecular Pharmacology: 25 Years FMP

01.-02. June 2017



Please register here



Research Highlights

Entry from: 22.02.2017  
Category: Research Highlights

New insights into the nerve cell: What really happens when a vesicle fuses with the cell membrane

NEURON They are not visible to the naked eye, and yet so many different things depend on them: the vesicles in our synapses. Much research has been done into the fact that these tiny bubbles secrete messenger substances and, in the process, fuse with the cell (...)[more]

Entry from: 02.02.2017  
Category: Research Highlights

Gamma oscillations coordinate food seeking

NATURE Seeking of food is a crucial survival instinct. However, until recently, little was known about how brain regulates this behavior. Scientists at the Leibniz-Institut für Molekulare Pharmakologie (FMP) and NeuroCure Cluster of Excellence in Berlin (...)[more]

Entry from: 20.07.2016  

A “time switch” in the brain improves sense of smell

NATURE COMMUNICATIONS When the brain processes olfactory stimuli, it differentiates between similar smells using subtly modulated signals. Brain examinations and behavioral studies in mice have now shown that neurons with inhibiting characteristics play a key (...)[more]

Entry from: 22.01.2016  
Category: Research Highlights

Milestone for Parkinson's research: The amyloid protein α-synuclein has been visualised in the cell for the first time

NATURE AND NATURE COMMUNICATIONS The protein α-synuclein plays an important role in Parkinson's and other neurodegenerative diseases. Although a considerable amount is known about the structure of the protein within the Parkinson's-typical amyloid deposits, (...)[more]

Entry from: 13.01.2016  
Category: Research Highlights

Muscle weakness: Berlin scientists unravel defects in rare hereditary disease myotubular myopathy

NATURE Tiny deviations in the body's cells can sometimes have severe consequences. Researchers from Berlin have discovered why cells from patients suffering from the rare muscular disease myotubular myopathy cannot function properly. Through the paper published (...)[more]


Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Campus Berlin-Buch
Robert-Roessle-Str. 10
13125 Berlin, Germany
+4930 94793 - 100 
+4930 94793 - 109 (Fax)